| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Diamond-Blackfan | 19 | 2020 | 138 | 3.100 |
Why?
|
| Ribosomal Proteins | 14 | 2018 | 370 | 1.330 |
Why?
|
| Bone Marrow Diseases | 5 | 2018 | 233 | 1.270 |
Why?
|
| Anemia, Aplastic | 7 | 2018 | 230 | 1.240 |
Why?
|
| Hemoglobinuria, Paroxysmal | 2 | 2018 | 94 | 1.170 |
Why?
|
| Colony-Stimulating Factors | 18 | 1994 | 218 | 0.980 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2018 | 604 | 0.880 |
Why?
|
| Hematopoietic Stem Cells | 33 | 2019 | 3394 | 0.800 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 8 | 2005 | 114 | 0.770 |
Why?
|
| Interleukin-3 | 18 | 2005 | 425 | 0.750 |
Why?
|
| Hematopoiesis | 22 | 2019 | 2049 | 0.730 |
Why?
|
| Fanconi Anemia | 7 | 2001 | 324 | 0.670 |
Why?
|
| Erythropoiesis | 15 | 2017 | 684 | 0.660 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2016 | 12 | 0.570 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2016 | 121 | 0.530 |
Why?
|
| Receptors, Erythropoietin | 5 | 1997 | 144 | 0.530 |
Why?
|
| Bone Marrow | 15 | 2019 | 2909 | 0.510 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2016 | 118 | 0.510 |
Why?
|
| Mutation | 17 | 2019 | 30015 | 0.450 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 568 | 0.430 |
Why?
|
| Hematopoietic Cell Growth Factors | 6 | 1993 | 98 | 0.410 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 15 | 1998 | 888 | 0.380 |
Why?
|
| Bone Marrow Cells | 18 | 2006 | 2409 | 0.350 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2018 | 1394 | 0.330 |
Why?
|
| Tissue Donors | 3 | 2018 | 2329 | 0.330 |
Why?
|
| Antigens, CD34 | 10 | 2019 | 658 | 0.280 |
Why?
|
| Growth Substances | 10 | 1994 | 768 | 0.260 |
Why?
|
| Granulocytes | 9 | 2019 | 551 | 0.250 |
Why?
|
| Erythropoietin | 8 | 2005 | 719 | 0.250 |
Why?
|
| Antigens, Surface | 6 | 1986 | 1606 | 0.250 |
Why?
|
| Neutrophils | 2 | 2016 | 3763 | 0.250 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2018 | 5671 | 0.240 |
Why?
|
| Recombinant Proteins | 16 | 1997 | 6520 | 0.240 |
Why?
|
| Anemia, Sideroblastic | 3 | 2018 | 109 | 0.230 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2018 | 3611 | 0.220 |
Why?
|
| Erythroid Precursor Cells | 5 | 2006 | 212 | 0.210 |
Why?
|
| GATA1 Transcription Factor | 3 | 2014 | 296 | 0.210 |
Why?
|
| Interleukin-1 | 6 | 1991 | 1248 | 0.200 |
Why?
|
| Cells, Cultured | 23 | 2015 | 18937 | 0.190 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2021 | 83 | 0.190 |
Why?
|
| Recombinant Fusion Proteins | 5 | 1998 | 3730 | 0.180 |
Why?
|
| Receptors, Virus | 2 | 2005 | 639 | 0.180 |
Why?
|
| Cell Division | 12 | 1999 | 4457 | 0.180 |
Why?
|
| Antigens, CD | 6 | 2015 | 3998 | 0.180 |
Why?
|
| Gene Expression Regulation | 9 | 2006 | 11874 | 0.170 |
Why?
|
| Mutation, Missense | 3 | 2019 | 2570 | 0.170 |
Why?
|
| Colony-Forming Units Assay | 13 | 2000 | 351 | 0.170 |
Why?
|
| Gene Transfer Techniques | 3 | 2000 | 1202 | 0.170 |
Why?
|
| Red-Cell Aplasia, Pure | 1 | 1999 | 27 | 0.170 |
Why?
|
| Leucine | 2 | 2020 | 548 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2001 | 453 | 0.160 |
Why?
|
| Moloney murine leukemia virus | 1 | 1999 | 109 | 0.160 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1999 | 93 | 0.160 |
Why?
|
| Anemia, Hemolytic, Congenital | 1 | 2019 | 71 | 0.160 |
Why?
|
| Spectrin | 1 | 2019 | 170 | 0.160 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2018 | 10 | 0.160 |
Why?
|
| Portraits as Topic | 1 | 2018 | 32 | 0.160 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 210 | 0.150 |
Why?
|
| Receptors, Interleukin-3 | 1 | 1997 | 29 | 0.150 |
Why?
|
| MELAS Syndrome | 1 | 2018 | 56 | 0.150 |
Why?
|
| Erythrocyte Membrane | 1 | 2019 | 439 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3776 | 0.140 |
Why?
|
| Genetic Heterogeneity | 1 | 2001 | 733 | 0.140 |
Why?
|
| Dexamethasone | 1 | 2005 | 1946 | 0.140 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1999 | 581 | 0.140 |
Why?
|
| Receptors, Transferrin | 3 | 2015 | 291 | 0.140 |
Why?
|
| Acidosis, Lactic | 1 | 2018 | 146 | 0.140 |
Why?
|
| Capsid | 1 | 1999 | 433 | 0.130 |
Why?
|
| Siblings | 2 | 2018 | 824 | 0.130 |
Why?
|
| RNA Interference | 1 | 2005 | 2829 | 0.130 |
Why?
|
| Thrombophilia | 1 | 2019 | 306 | 0.130 |
Why?
|
| Humans | 105 | 2021 | 760740 | 0.130 |
Why?
|
| Receptors, Interleukin | 1 | 1996 | 243 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 630 | 0.120 |
Why?
|
| Viral Envelope Proteins | 1 | 1999 | 640 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4569 | 0.120 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 2015 | 547 | 0.120 |
Why?
|
| RNA, Ribosomal | 2 | 2013 | 227 | 0.120 |
Why?
|
| Cell Differentiation | 16 | 2019 | 11512 | 0.120 |
Why?
|
| Blood Transfusion | 2 | 2020 | 1300 | 0.120 |
Why?
|
| RNA Splicing | 1 | 2019 | 898 | 0.120 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2018 | 386 | 0.120 |
Why?
|
| Methionine | 1 | 2016 | 572 | 0.110 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1993 | 41 | 0.110 |
Why?
|
| Stem Cell Factor | 3 | 2005 | 195 | 0.110 |
Why?
|
| Vitamin B 12 | 1 | 2016 | 524 | 0.110 |
Why?
|
| Homocysteine | 1 | 2016 | 637 | 0.110 |
Why?
|
| Protein Biosynthesis | 2 | 2014 | 2100 | 0.110 |
Why?
|
| RNA, Messenger | 11 | 2014 | 12759 | 0.100 |
Why?
|
| Pedigree | 6 | 2015 | 4539 | 0.100 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 974 | 0.100 |
Why?
|
| Cell Line | 11 | 2008 | 15577 | 0.100 |
Why?
|
| Hip Joint | 1 | 2019 | 1014 | 0.100 |
Why?
|
| Ribosomes | 3 | 2018 | 500 | 0.100 |
Why?
|
| Arthroscopy | 1 | 2019 | 969 | 0.100 |
Why?
|
| Genetic Linkage | 4 | 2006 | 2340 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 1999 | 1662 | 0.090 |
Why?
|
| Cell Cycle | 3 | 1999 | 2929 | 0.090 |
Why?
|
| Perioperative Care | 1 | 2019 | 1037 | 0.090 |
Why?
|
| Histocompatibility Antigens Class II | 6 | 1986 | 1434 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 1999 | 3688 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2012 | 2916 | 0.090 |
Why?
|
| Receptors, Colony-Stimulating Factor | 4 | 1994 | 50 | 0.090 |
Why?
|
| Genes, myb | 1 | 2009 | 18 | 0.090 |
Why?
|
| Frameshift Mutation | 1 | 2012 | 392 | 0.090 |
Why?
|
| Gene Deletion | 2 | 2018 | 2659 | 0.090 |
Why?
|
| T-Lymphocytes | 11 | 1999 | 10175 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1852 | 0.090 |
Why?
|
| Exons | 2 | 2018 | 2381 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 8 | 2000 | 2690 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 1999 | 3392 | 0.080 |
Why?
|
| Molecular Sequence Data | 7 | 2008 | 17630 | 0.080 |
Why?
|
| RNA, Small Interfering | 4 | 2013 | 3419 | 0.080 |
Why?
|
| Globins | 3 | 2017 | 405 | 0.080 |
Why?
|
| Transfection | 5 | 1996 | 5765 | 0.080 |
Why?
|
| Glycoproteins | 3 | 1987 | 2200 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 1608 | 0.080 |
Why?
|
| DNA Mutational Analysis | 4 | 2012 | 4110 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2017 | 1051 | 0.080 |
Why?
|
| Infant | 14 | 2018 | 36157 | 0.080 |
Why?
|
| Base Sequence | 6 | 2012 | 12420 | 0.080 |
Why?
|
| G1 Phase | 1 | 2009 | 403 | 0.080 |
Why?
|
| Leukemia | 5 | 1997 | 1520 | 0.080 |
Why?
|
| Signal Transduction | 6 | 2019 | 23415 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 1988 | 4340 | 0.070 |
Why?
|
| Fibroblasts | 6 | 2015 | 4140 | 0.070 |
Why?
|
| Animals | 33 | 2015 | 168202 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1996 | 4512 | 0.070 |
Why?
|
| Genetic Complementation Test | 2 | 2017 | 555 | 0.070 |
Why?
|
| Mice | 18 | 2006 | 81368 | 0.070 |
Why?
|
| Thumb | 1 | 2008 | 232 | 0.070 |
Why?
|
| Haplotypes | 2 | 2004 | 2713 | 0.070 |
Why?
|
| Endothelium, Vascular | 3 | 1988 | 4433 | 0.070 |
Why?
|
| Erythroblasts | 3 | 1999 | 142 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2422 | 0.070 |
Why?
|
| Phosphorylation | 5 | 2019 | 8311 | 0.060 |
Why?
|
| Clone Cells | 4 | 1999 | 1657 | 0.060 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1983 | 176 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2005 | 866 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2012 | 5034 | 0.060 |
Why?
|
| Mesoderm | 1 | 1988 | 674 | 0.060 |
Why?
|
| Stem Cells | 4 | 2005 | 3514 | 0.060 |
Why?
|
| Erythrocytes | 6 | 1987 | 2410 | 0.060 |
Why?
|
| Interleukins | 1 | 1990 | 783 | 0.060 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 5 | 1997 | 629 | 0.060 |
Why?
|
| Cell Proliferation | 4 | 2009 | 10429 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 1422 | 0.060 |
Why?
|
| Retroviridae | 2 | 2005 | 851 | 0.060 |
Why?
|
| Macrophages | 5 | 1995 | 5758 | 0.060 |
Why?
|
| Endothelium | 1 | 1987 | 764 | 0.060 |
Why?
|
| Blotting, Northern | 3 | 2012 | 1545 | 0.060 |
Why?
|
| Cell Separation | 8 | 2006 | 1718 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 1993 | 1589 | 0.060 |
Why?
|
| Fibronectins | 1 | 1987 | 723 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 10 | 1994 | 9171 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2019 | 2553 | 0.050 |
Why?
|
| Drug Synergism | 4 | 1994 | 1756 | 0.050 |
Why?
|
| RNA | 2 | 2009 | 2713 | 0.050 |
Why?
|
| K562 Cells | 1 | 2005 | 641 | 0.050 |
Why?
|
| Osteopetrosis | 1 | 1983 | 43 | 0.050 |
Why?
|
| Luciferases | 1 | 2005 | 712 | 0.050 |
Why?
|
| Monocytes | 5 | 2019 | 2565 | 0.050 |
Why?
|
| Genetic Association Studies | 3 | 2018 | 2734 | 0.050 |
Why?
|
| Cleft Palate | 1 | 2008 | 589 | 0.050 |
Why?
|
| Polymorphism, Genetic | 3 | 2010 | 4242 | 0.050 |
Why?
|
| Male | 29 | 2020 | 360402 | 0.050 |
Why?
|
| Introns | 1 | 2005 | 968 | 0.050 |
Why?
|
| Flow Cytometry | 6 | 2005 | 5863 | 0.050 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1981 | 69 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2006 | 1088 | 0.050 |
Why?
|
| Chromosome Mapping | 3 | 2008 | 4611 | 0.050 |
Why?
|
| Receptors, Cell Surface | 4 | 2000 | 2802 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 1989 | 0.050 |
Why?
|
| Cations | 1 | 2021 | 238 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2019 | 2013 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 4172 | 0.050 |
Why?
|
| Lod Score | 1 | 2001 | 600 | 0.040 |
Why?
|
| Cell Membrane | 3 | 1987 | 3680 | 0.040 |
Why?
|
| Dyskeratosis Congenita | 1 | 2000 | 73 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2001 | 350 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 1034 | 0.040 |
Why?
|
| Killer Cells, Natural | 4 | 1999 | 2191 | 0.040 |
Why?
|
| Permeability | 1 | 2021 | 721 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2006 | 14388 | 0.040 |
Why?
|
| Reference Values | 1 | 2006 | 4919 | 0.040 |
Why?
|
| Cyclophosphamide | 3 | 1997 | 2218 | 0.040 |
Why?
|
| Female | 27 | 2020 | 392203 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 1999 | 254 | 0.040 |
Why?
|
| Amino Acid Sequence | 5 | 2008 | 13442 | 0.040 |
Why?
|
| Liver | 3 | 2009 | 7512 | 0.040 |
Why?
|
| Primary Myelofibrosis | 1 | 1980 | 209 | 0.040 |
Why?
|
| Pancreatic Diseases | 1 | 2000 | 344 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 8516 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2012 | 22153 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 1989 | 186 | 0.040 |
Why?
|
| Phenotype | 7 | 2018 | 16572 | 0.040 |
Why?
|
| Adolescent | 12 | 2020 | 88247 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 2916 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 1999 | 344 | 0.040 |
Why?
|
| Blood Specimen Collection | 2 | 1997 | 238 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 7583 | 0.040 |
Why?
|
| Allyl Compounds | 1 | 2017 | 22 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1999 | 346 | 0.040 |
Why?
|
| Interleukin-2 | 5 | 1996 | 1888 | 0.030 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2019 | 344 | 0.030 |
Why?
|
| Time Factors | 7 | 2005 | 39908 | 0.030 |
Why?
|
| Culture Media | 3 | 1989 | 895 | 0.030 |
Why?
|
| Thymidine | 1 | 1996 | 297 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2013 | 3088 | 0.030 |
Why?
|
| Child, Preschool | 9 | 2020 | 42193 | 0.030 |
Why?
|
| Blotting, Southern | 2 | 2000 | 777 | 0.030 |
Why?
|
| Janus Kinase 1 | 1 | 1996 | 107 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2010 | 410 | 0.030 |
Why?
|
| Bone Marrow Purging | 2 | 1996 | 108 | 0.030 |
Why?
|
| Janus Kinase 2 | 2 | 1996 | 560 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2005 | 4117 | 0.030 |
Why?
|
| Blood Component Removal | 1 | 1997 | 132 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 1996 | 456 | 0.030 |
Why?
|
| Clonal Anergy | 1 | 1996 | 169 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2747 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2000 | 1084 | 0.030 |
Why?
|
| Heterozygote | 2 | 2019 | 2780 | 0.030 |
Why?
|
| Child | 14 | 2020 | 80089 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 3447 | 0.030 |
Why?
|
| Stromal Cells | 2 | 1998 | 1329 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1056 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2005 | 2160 | 0.030 |
Why?
|
| src Homology Domains | 1 | 1996 | 361 | 0.030 |
Why?
|
| Neutropenia | 1 | 2000 | 885 | 0.030 |
Why?
|
| Myeloproliferative Disorders | 1 | 1981 | 611 | 0.030 |
Why?
|
| Erythroid Cells | 1 | 2017 | 238 | 0.030 |
Why?
|
| Platelet Count | 2 | 1998 | 780 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 1981 | 1768 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2001 | 2601 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 1999 | 1827 | 0.030 |
Why?
|
| HLA Antigens | 4 | 1986 | 1327 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2000 | 5789 | 0.030 |
Why?
|
| Lymphocytes | 7 | 1998 | 2604 | 0.030 |
Why?
|
| Interleukin-11 | 1 | 1994 | 58 | 0.030 |
Why?
|
| Syndrome | 1 | 2000 | 3268 | 0.030 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 2 | 1986 | 150 | 0.030 |
Why?
|
| Isoantigens | 1 | 1996 | 551 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 5 | 2015 | 22117 | 0.030 |
Why?
|
| Mice, SCID | 1 | 1999 | 2625 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 1994 | 619 | 0.030 |
Why?
|
| Apoptosis | 2 | 2008 | 9476 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2015 | 412 | 0.030 |
Why?
|
| Tyrosine | 2 | 1996 | 1440 | 0.030 |
Why?
|
| Leukocyte Count | 2 | 1995 | 1597 | 0.030 |
Why?
|
| Aftercare | 1 | 2019 | 913 | 0.030 |
Why?
|
| Adult | 17 | 2020 | 220995 | 0.030 |
Why?
|
| Graft vs Host Disease | 3 | 1996 | 3026 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1999 | 1348 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 1748 | 0.030 |
Why?
|
| DNA | 4 | 2008 | 7196 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2000 | 26183 | 0.020 |
Why?
|
| Antilymphocyte Serum | 1 | 2013 | 485 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 473 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2015 | 718 | 0.020 |
Why?
|
| Genomic Library | 1 | 1991 | 189 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 1962 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1650 | 0.020 |
Why?
|
| Endocytosis | 1 | 2015 | 955 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 1994 | 651 | 0.020 |
Why?
|
| Young Adult | 4 | 2020 | 59191 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 1996 | 982 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 3 | 1991 | 531 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2013 | 776 | 0.020 |
Why?
|
| Sialoglycoproteins | 2 | 1983 | 315 | 0.020 |
Why?
|
| Blood Proteins | 3 | 1986 | 1172 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1996 | 3074 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 724 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 1999 | 2382 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1993 | 2467 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 1998 | 1182 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 1996 | 1250 | 0.020 |
Why?
|
| Interferon-gamma | 2 | 1990 | 3145 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1993 | 2185 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1993 | 1433 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 1058 | 0.020 |
Why?
|
| Quinazolines | 1 | 2017 | 1371 | 0.020 |
Why?
|
| Graft Survival | 2 | 1999 | 3814 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1996 | 2425 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2000 | 2851 | 0.020 |
Why?
|
| North America | 1 | 2013 | 1273 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1994 | 1964 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1995 | 687 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1997 | 1834 | 0.020 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1990 | 173 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5239 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 1998 | 9586 | 0.020 |
Why?
|
| Ribosome Subunits, Large | 1 | 2008 | 4 | 0.020 |
Why?
|
| Ribosome Subunits, Small | 1 | 2008 | 5 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 1998 | 10754 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1996 | 1779 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1993 | 1503 | 0.020 |
Why?
|
| Cell Survival | 1 | 1999 | 5780 | 0.020 |
Why?
|
| Phagocytes | 1 | 1990 | 295 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39062 | 0.020 |
Why?
|
| Autophagy | 1 | 2017 | 1327 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 9461 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1996 | 951 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1996 | 3965 | 0.020 |
Why?
|
| Estrogens | 1 | 1995 | 1521 | 0.020 |
Why?
|
| Hylobates | 1 | 1987 | 13 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1995 | 1372 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2000 | 1896 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 1490 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2001 | 3533 | 0.020 |
Why?
|
| Prognosis | 3 | 2020 | 29601 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 1988 | 813 | 0.020 |
Why?
|
| Hodgkin Disease | 1 | 1995 | 1378 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1987 | 306 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2008 | 322 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8619 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1988 | 310 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 18220 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 1995 | 2208 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 6074 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1994 | 1971 | 0.020 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2006 | 56 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1988 | 386 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1988 | 418 | 0.020 |
Why?
|
| Nucleoside Transport Proteins | 1 | 1986 | 8 | 0.020 |
Why?
|
| Point Mutation | 2 | 2005 | 1595 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 1987 | 426 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 1986 | 239 | 0.020 |
Why?
|
| Anemia | 1 | 2015 | 1504 | 0.020 |
Why?
|
| Proteins | 2 | 1998 | 6030 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2006 | 78 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1991 | 1743 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 2 | 1981 | 1077 | 0.020 |
Why?
|
| Venous Thromboembolism | 1 | 2019 | 1866 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 1990 | 496 | 0.020 |
Why?
|
| Giant Cell Tumors | 1 | 1986 | 89 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1996 | 2896 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1986 | 212 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1990 | 1878 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 5463 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1991 | 1409 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 1851 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1986 | 378 | 0.020 |
Why?
|
| Cytokines | 1 | 2000 | 7373 | 0.010 |
Why?
|
| Cricetulus | 1 | 1986 | 814 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 2020 | 0.010 |
Why?
|
| Blood Group Antigens | 1 | 1986 | 182 | 0.010 |
Why?
|
| Protein Binding | 1 | 1996 | 9345 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1986 | 897 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1987 | 963 | 0.010 |
Why?
|
| Kinetics | 1 | 1991 | 6370 | 0.010 |
Why?
|
| Heme | 1 | 2005 | 313 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2008 | 1386 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2019 | 4785 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2006 | 748 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 516 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2005 | 638 | 0.010 |
Why?
|
| I Blood-Group System | 1 | 1982 | 8 | 0.010 |
Why?
|
| Cyclosporins | 1 | 1983 | 216 | 0.010 |
Why?
|
| Genes | 1 | 1987 | 1823 | 0.010 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 1983 | 99 | 0.010 |
Why?
|
| Cricetinae | 1 | 1986 | 2424 | 0.010 |
Why?
|
| Receptors, Fc | 2 | 1989 | 534 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1994 | 3607 | 0.010 |
Why?
|
| X Chromosome | 3 | 1995 | 816 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 4745 | 0.010 |
Why?
|
| Placenta | 1 | 1991 | 1709 | 0.010 |
Why?
|
| Tumor Virus Infections | 2 | 1981 | 435 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1987 | 4172 | 0.010 |
Why?
|
| Middle Aged | 8 | 2020 | 220603 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2018 | 41464 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2005 | 942 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1983 | 509 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1988 | 2202 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1982 | 601 | 0.010 |
Why?
|
| Family Health | 1 | 2005 | 1253 | 0.010 |
Why?
|
| Forearm | 1 | 1983 | 427 | 0.010 |
Why?
|
| Antigens, Differentiation | 2 | 1996 | 908 | 0.010 |
Why?
|
| Blood Cell Count | 2 | 1997 | 397 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1986 | 1602 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 1982 | 380 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1986 | 3088 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2000 | 146 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2019 | 64572 | 0.010 |
Why?
|
| Karyotyping | 1 | 1981 | 1171 | 0.010 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2000 | 123 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10759 | 0.010 |
Why?
|
| Rosette Formation | 3 | 1986 | 152 | 0.010 |
Why?
|
| Cell Communication | 1 | 1986 | 1654 | 0.010 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 1998 | 97 | 0.010 |
Why?
|
| Immune Sera | 1 | 1998 | 605 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2000 | 472 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2000 | 662 | 0.010 |
Why?
|
| Histocytochemistry | 2 | 1990 | 696 | 0.010 |
Why?
|
| Epitopes | 2 | 1981 | 2501 | 0.010 |
Why?
|
| Mitomycin | 1 | 1998 | 263 | 0.010 |
Why?
|
| Hematocrit | 1 | 1998 | 623 | 0.010 |
Why?
|
| Neoplasms | 1 | 2006 | 22131 | 0.010 |
Why?
|
| Cell Count | 2 | 1995 | 1834 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1996 | 101 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1996 | 507 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1996 | 6126 | 0.010 |
Why?
|
| Leukapheresis | 1 | 1995 | 134 | 0.010 |
Why?
|
| Immunization | 1 | 1980 | 1217 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 1997 | 961 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1995 | 12116 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 1995 | 195 | 0.010 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1995 | 66 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 255 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1996 | 365 | 0.010 |
Why?
|
| Rabbits | 1 | 1981 | 4770 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1983 | 4802 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1998 | 1336 | 0.010 |
Why?
|
| Spleen | 1 | 2000 | 2286 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1995 | 207 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1995 | 208 | 0.010 |
Why?
|
| Antibodies, Viral | 2 | 1981 | 3149 | 0.010 |
Why?
|
| Species Specificity | 1 | 1997 | 2410 | 0.010 |
Why?
|
| Genome, Human | 1 | 2006 | 4421 | 0.010 |
Why?
|
| Chickens | 1 | 1995 | 858 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1981 | 1985 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1996 | 1525 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 1997 | 858 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 1996 | 1146 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 1981 | 4533 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 74128 | 0.010 |
Why?
|
| Tretinoin | 1 | 1995 | 519 | 0.010 |
Why?
|
| Radiography | 1 | 1983 | 6961 | 0.010 |
Why?
|
| Nitroblue Tetrazolium | 1 | 1990 | 16 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1997 | 2328 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1991 | 436 | 0.010 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1991 | 262 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1998 | 4845 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1995 | 2112 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1997 | 1901 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1991 | 601 | 0.010 |
Why?
|
| Superoxides | 1 | 1990 | 387 | 0.010 |
Why?
|
| Pregnancy | 1 | 1991 | 29869 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1990 | 641 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1994 | 1642 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 1986 | 7847 | 0.000 |
Why?
|
| Receptors, Androgen | 1 | 1995 | 1079 | 0.000 |
Why?
|
| Fetus | 2 | 1986 | 1862 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1301 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 20077 | 0.000 |
Why?
|
| Tissue and Organ Procurement | 1 | 1996 | 962 | 0.000 |
Why?
|
| Swine | 1 | 1997 | 5908 | 0.000 |
Why?
|
| Cell Fractionation | 1 | 1987 | 249 | 0.000 |
Why?
|
| Immunotherapy | 1 | 1983 | 4642 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1991 | 1390 | 0.000 |
Why?
|
| Tritium | 1 | 1987 | 706 | 0.000 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1986 | 110 | 0.000 |
Why?
|
| Receptors, IgG | 1 | 1989 | 558 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1989 | 1349 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 2214 | 0.000 |
Why?
|
| Fetal Hemoglobin | 1 | 1987 | 346 | 0.000 |
Why?
|
| Thioguanine | 1 | 1983 | 45 | 0.000 |
Why?
|
| Interferon Type I | 1 | 1987 | 557 | 0.000 |
Why?
|
| Daunorubicin | 1 | 1983 | 157 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1987 | 974 | 0.000 |
Why?
|
| Photomicrography | 1 | 1981 | 71 | 0.000 |
Why?
|
| Aged | 3 | 2005 | 169092 | 0.000 |
Why?
|
| Glioblastoma | 1 | 1996 | 3481 | 0.000 |
Why?
|
| Infectious Mononucleosis | 1 | 1981 | 133 | 0.000 |
Why?
|
| Cytarabine | 1 | 1983 | 697 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1981 | 310 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1987 | 1347 | 0.000 |
Why?
|
| Antigens | 1 | 1986 | 1441 | 0.000 |
Why?
|
| Agammaglobulinemia | 1 | 1981 | 171 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 1996 | 4849 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1983 | 13635 | 0.000 |
Why?
|
| Immunoglobulin A | 1 | 1981 | 978 | 0.000 |
Why?
|
| Interferons | 1 | 1981 | 702 | 0.000 |
Why?
|
| Skin | 1 | 1991 | 4472 | 0.000 |
Why?
|
| Antigens, Viral | 1 | 1981 | 988 | 0.000 |
Why?
|
| Sheep | 1 | 1980 | 1436 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1981 | 1526 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1981 | 1550 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 11107 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1983 | 6305 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1996 | 13383 | 0.000 |
Why?
|
| Immunity, Innate | 1 | 1981 | 3045 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1996 | 20988 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1983 | 11118 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1983 | 7995 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1981 | 9310 | 0.000 |
Why?
|